Acadia Healthcare Company Inc (NASDAQ:ACHC) has received a consensus recommendation of “Hold” from the fourteen research firms that are presently covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, eight have issued a hold recommendation and three have assigned a buy recommendation to the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $36.80.
Several research firms have issued reports on ACHC. TheStreet lowered shares of Timkensteel from a “c-” rating to a “d+” rating in a research report on Monday, June 17th. ValuEngine lowered shares of Viewray from a “buy” rating to a “hold” rating in a research report on Wednesday, April 24th. Deutsche Bank lowered shares of Cogent Communications from a “buy” rating to a “hold” rating in a research report on Thursday, May 2nd. BidaskClub lowered shares of Woodward, Inc.Common Stock from a “strong-buy” rating to a “buy” rating in a research report on Saturday. Finally, BMO Capital Markets restated a “hold” rating and issued a $45.00 price target on shares of SAP in a research report on Wednesday, May 1st.
Several institutional investors have recently modified their holdings of ACHC. Norges Bank acquired a new stake in shares of Acadia Healthcare during the 4th quarter valued at about $24,857,000. Neuberger Berman Group LLC boosted its position in shares of Acadia Healthcare by 89.3% during the 1st quarter. Neuberger Berman Group LLC now owns 1,658,751 shares of the company’s stock valued at $48,620,000 after acquiring an additional 782,480 shares in the last quarter. Clearbridge Investments LLC acquired a new stake in shares of Acadia Healthcare during the 1st quarter valued at about $12,709,000. Elk Creek Partners LLC acquired a new stake in shares of Acadia Healthcare during the 1st quarter valued at about $8,816,000. Finally, Dimensional Fund Advisors LP boosted its position in shares of Acadia Healthcare by 3.3% during the 4th quarter. Dimensional Fund Advisors LP now owns 5,591,881 shares of the company’s stock valued at $143,767,000 after acquiring an additional 176,791 shares in the last quarter.
Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Tuesday, April 30th. The company reported $0.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.35 by $0.04. The company had revenue of $760.60 million for the quarter, compared to analyst estimates of $762.02 million. Acadia Healthcare had a negative net margin of 6.50% and a positive return on equity of 7.33%. The business’s quarterly revenue was up 2.5% on a year-over-year basis. During the same period last year, the business posted $0.52 EPS. As a group, research analysts anticipate that Acadia Healthcare will post 2.19 EPS for the current year.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States, the United Kingdom, and Puerto Rico.
Featured Story: Overbought
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.